GPER activation ameliorates aortic remodeling induced by salt-sensitive hypertension

Am J Physiol Heart Circ Physiol. 2016 Apr 15;310(8):H953-61. doi: 10.1152/ajpheart.00631.2015. Epub 2016 Feb 12.

Abstract

The mRen2 female rat is an estrogen- and salt-sensitive model of hypertension that reflects the higher pressure and salt sensitivity associated with menopause. We previously showed that the G protein-coupled estrogen receptor (GPER) mediates estrogenic effects in this model. The current study hypothesized that GPER protects against vascular injury during salt loading. Intact mRen2 female rats were fed a normal (NS; 0.5% Na(+)) or high-salt diet (HS; 4% Na(+)) for 10 wk, which significantly increased systolic blood pressure (149 ± 5 vs. 224 ± 8 mmHg;P< 0.001). Treatment with the selective GPER agonist G-1 for 2 wk did not alter salt-sensitive hypertension (216 ± 4 mmHg;P> 0.05) or ex vivo vascular responses to angiotensin II or phenylephrine (P> 0.05). However, G-1 significantly attenuated salt-induced aortic remodeling assessed by media-to-lumen ratio (NS: 0.43; HS+veh: 0.89; HS+G-1: 0.61;P< 0.05). Aortic thickening was not accompanied by changes in collagen, elastin, or medial proliferation. However, HS induced increases in medial layer glycosaminoglycans (0.07 vs. 0.42 mm(2);P< 0.001) and lipid peroxidation (0.11 vs. 0.51 mm(2);P< 0.01), both of which were reduced by G-1 (0.20 mm(2)and 0.23 mm(2); both P< 0.05). We conclude that GPER's beneficial actions in the aorta of salt-loaded mRen2 females occur independently of changes in blood pressure and vasoreactivity. GPER-induced attenuation of aortic remodeling was associated with a reduction in oxidative stress and decreased accumulation of glycosaminoglycans. Endogenous activation of GPER may protect females from salt- and pressure-induced vascular damage.

Keywords: estrogen; glycosaminoglycans; oxidative stress; salt-sensitive hypertension; vascular remodeling.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin II / pharmacology
  • Animals
  • Animals, Congenic
  • Aorta / drug effects*
  • Aorta / metabolism
  • Aorta / pathology
  • Aorta / physiopathology
  • Blood Pressure / drug effects
  • Cyclopentanes / pharmacology*
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Female
  • Genotype
  • Glycosaminoglycans / metabolism
  • Hypertension / genetics
  • Hypertension / metabolism*
  • Hypertension / pathology
  • Hypertension / physiopathology
  • Lipid Peroxidation / drug effects
  • Oxidative Stress / drug effects
  • Phenylephrine / pharmacology
  • Quinolines / pharmacology*
  • Rats, Transgenic
  • Receptors, G-Protein-Coupled / agonists*
  • Receptors, G-Protein-Coupled / metabolism
  • Renin / genetics
  • Renin / metabolism
  • Sodium Chloride, Dietary*
  • Time Factors
  • Vascular Remodeling / drug effects*

Substances

  • 1-(4-(6-bromobenzo(1,3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta(c)quinolin-8-yl)ethanone
  • Cyclopentanes
  • Glycosaminoglycans
  • Gper1 protein, rat
  • Quinolines
  • Receptors, G-Protein-Coupled
  • Sodium Chloride, Dietary
  • Angiotensin II
  • Phenylephrine
  • Renin